Figure S1 from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

• DOI: 10.1158/1078-0432.22472883.v1
• Publication Date: 2023-04-01T01:35:03Z
• Authors: Robyn D. Gartrell; Douglas K. Marks; Emanuelle M. Rizk; Margaret Bogardus; Camille L. Gérard; Luke W. Barker; Yichun Fu; Camden L. Esancy; Gen Li; Jiayi Ji; Shumin Rui; Marc S. Ernstoff; Bret Taback; Sarabjot Pabla; Rui Chang; Sandra J. Lee; John J. Krolewski; Carl Morrison; Basil A. Horst; Yvonne M. Saenger

<p>Melanoma Immune Profile (MIP) correlates with metastasis cohort including patients local recurrence only.</p>